Stock Events

Ultragenyx Pharmaceutical (RARE.MX) Q4 2017 Earnings

2NovConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-35.71
-33.98
-32.25
-30.51

Details

Expected EPS
-35.3175498
Actual EPS
-35.507429099999996
Surprise EPS
-0.19
Surprise Percent
+0.54%

Description

Ultragenyx Pharmaceutical (RARE.MX) has reported earnings of -35.507429099999996 per share for Q4 2017.

0 Comments

Share your thoughts